Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Københavns Universitets forskningsportal Forside
Hjælp og OSS
Dansk
English
Forside
Profiler
Publikation
Forskningsenheder
Presse/medier
Aktiviteter
Priser
???studenttheses???
Forskningsdatasæt
Søg efter ekspertise, navn eller tilknytning
HER2-targeted therapy in breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors
Dorte Lisbet Nielsen
, Michael Andersson, Claus Kamby
Institut for Klinisk Medicin
95
Citationer (Scopus)
Oversigt
Fingeraftryk
Fingeraftryk
Dyk ned i forskningsemnerne om 'HER2-targeted therapy in breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors'. Sammen danner de et unikt fingeraftryk.
Sorter
Vægt
Alfabetisk
Pharmacology, Toxicology and Pharmaceutical Science
Monoclonal Antibody
100%
Trastuzumab
100%
Protein Tyrosine Kinase Inhibitor
100%
Breast Cancer
100%
Metastatic Breast Cancer
40%
Gamma Urogastrone
20%
Capecitabine
20%
Blood-Brain Barrier
20%
Neoplasm
20%
Epidermal Growth Factor Receptor
20%
Overall Survival
20%
Disease Free Survival
20%
Tyrosine Kinase Receptor
20%
Chemotherapy
20%
Keyphrases
HER2-targeted Therapy
100%
Lapatinib
40%
Preoperative Setting
20%
Pathological Complete Response
20%
HER2-positive Early Breast Cancer
20%
Capecitabine
20%
Taxanes
20%
HER2-positive Metastatic Breast Cancer
20%
Vinorelbine
20%
Optimal Selection
20%